Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
Create a free accountThis page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Prime Medicine, Inc.Listing on record | Buy | $10M | conv 79ClusterUnusual size+1 | SEC | |
Neumora Therapeutics, Inc.Listing on record | Buy | $371.9K | conv 35Cluster | SEC | |
Neumora Therapeutics, Inc.Listing on record | Buy | $40.2K | conv 33Cluster | SEC | |
Neumora Therapeutics, Inc.Listing on record | Buy | $134.7K | conv 33Cluster | SEC | |
Neumora Therapeutics, Inc.Listing on record | Buy | $745.2K | conv 50ClusterFirst in 12mo | SEC | |
Neumora Therapeutics, Inc.Listing on record | Buy | $63.8K | conv 33Cluster | SEC | |
Neumora Therapeutics, Inc.Listing on record | Buy | $327.3K | conv 42Cluster | SEC | |
Neumora Therapeutics, Inc.Listing on record | Buy | $272.6K | conv 50ClusterFirst in 12mo | SEC |